XML 70 R33.htm IDEA: XBRL DOCUMENT v3.19.3
Note 25 - Share-based Compensation Expenses
 9 Months Ended
Sep. 30, 2019
Notes to Financial Statements  
Share-based Payment Arrangement [Text Block]
25.
 Share-based compensation expenses
 
In
January 2019,
the Company granted and issued
30,000
shares of the Company’s restricted common stock to
one
of its independent directors, in exchange for his services to the Company for the year ending
December 31, 2019.
These shares were valued at
US$1.77
per share, the closing bid price of the Company’s common stock on the date of grant. Total compensation expense is amortized over the requisite service period. For the
nine
and
three
months ended
September 30, 2019,
compensation expense recognized was approximately
US$40,000
and
US$14,000,
respectively.
 
In
December 2018,
the Company granted and issued
250,000
shares of the Company restricted common stock to a management consulting and advisory service provider in exchange for its service for a
one
-year period. These shares were valued at
US$1.43
per share, the closing bid price of the Company’s common stock on the date of grant. The Company recorded the related cost of approximately
US$358,000
as a prepayment asset in prepayment and deposit to suppliers upon grant and issuance of these fully-vested and nonforfeitable shares. Total compensation expenses amortized for the
nine
and
three
months ended
September 30, 2019
was approximately
US$267,000
and
US$90,000,
respectively.
 
Options issued and outstanding as of
September 30, 2019
and their movements during the
nine
months then ended are as follows:
 
    Option Outstanding   Option Exercisable
   
Number of
underlying shares
   Weighted
Average
Remaining
Contractual
Life (Years)		   Weighted
Average
Exercise
Price		  
Number of
underlying shares
   Weighted
Average
Remaining
Contractual
Life (Years)		   Weighted
Average
Exercise
Price
                                                 
Balance, January 1, 2019    
835,216
      
2.04
     $
2.49
      
835,216
      
2.04
     $
2.49
  
Granted/Vested    
-
      
 
      
 
      
-
      
 
      
 
  
Forfeited    
-
      
 
      
 
      
-
      
 
      
 
  
Exercised    
-
      
 
      
 
      
-
      
 
      
 
  
Balance, September 30, 2019 (Unaudited)    
835,216
      
1.29
     $
2.49
      
835,216
      
1.29
     $
2.49
  
 
The aggregate intrinsic value of the above options was
zero
as of
September 30, 2019
and
December 31, 2018,
as their respective exercise prices were all higher than the Company’s closing stock price on the last trading day of each reporting period.
 
The table below summarized share-based compensation expenses recorded for the
nine
and
three
months ended
September 30, 2019
and
2018,
respectively:
 
    Nine Months Ended September 30,   Three Months Ended September 30,
    2019   2018   2019   2018
    US$(’000)   US$(’000)   US$(’000)   US$(’000)
    (Unaudited)   (Unaudited)   (Unaudited)   (Unaudited)
                                 
Sales and marketing expenses    
-
      
47
      
-
      
20
  
General and administrative expenses    
307
      
131
      
104
      
29
  
Research and development expenses    
-
      
37
      
-
      
15
  
Total    
307
      
215
      
104
      
64
  
 
The aggregate unrecognized share-based compensation expenses as of
September 30, 2019
and
December 31, 2018
was approximately
US$0.09
million and
US$0.34
million, respectively. All unrecognized share-based compensation expenses as of
September 30, 2019
will be recognized for the year ending
December 31, 2019.